Your browser doesn't support javascript.
loading
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.
Shah, Pallav L; Orton, Christopher M; Grinsztejn, Beatriz; Donaldson, Gavin C; Crabtree Ramírez, Brenda; Tonkin, James; Santos, Breno R; Cardoso, Sandra W; Ritchie, Andrew I; Conway, Francesca; Riberio, Maria P D; Wiseman, Dexter J; Tana, Anand; Vijayakumar, Bavithra; Caneja, Cielito; Leaper, Craig; Mann, Bobby; Samson, Anda; Bhavsar, Pankaj K; Boffito, Marta; Johnson, Mark R; Pozniak, Anton; Pelly, Michael.
Afiliação
  • Shah PL; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: pallav.shah@imperial.ac.uk.
  • Orton CM; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
  • Donaldson GC; National Heart and Lung Institute, Imperial College London, London, UK.
  • Crabtree Ramírez B; Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico.
  • Tonkin J; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Santos BR; Departamento de Infectología, Hospital Nossa Senhora da Conceição-Grupo Hospitalar Conceição, Porto Alegre, Brazil.
  • Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
  • Ritchie AI; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Conway F; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Riberio MPD; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
  • Wiseman DJ; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Tana A; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK.
  • Vijayakumar B; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Caneja C; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Leaper C; Chelsea & Westminster NHS Foundation Trust, London, UK.
  • Mann B; Chelsea & Westminster NHS Foundation Trust, London, UK.
  • Samson A; Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK.
  • Bhavsar PK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Boffito M; Chelsea & Westminster NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Johnson MR; Chelsea & Westminster NHS Foundation Trust, London, UK.
  • Pozniak A; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Pelly M; Chelsea & Westminster NHS Foundation Trust, London, UK.
Lancet Respir Med ; 11(5): 415-424, 2023 05.
Article em En | MEDLINE | ID: mdl-36528039

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article